Answers are grounded in this paper and cite their sources.
We identified gene signatures in resistant TNBC subtypes indicative of mechanisms of cisplatin. Our results indicate that response to cisplatin in TNBC has a complex foundation based on impact of treatment on distinct cellular pathways. We find that examination of expression data in the context of heterogeneous data such as drug-gene interactions leads to a better understanding of mechanisms at work in cancer therapy response.
No takes yet. Share an insight, caveat, or question.
Hill et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: